Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases
Top Cited Papers
- 1 July 2011
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 10 (7) , 649-656
- https://doi.org/10.1016/s1474-4422(11)70121-1
Abstract
No abstract availableFunding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Fondazione Cassa di Risparmio di Genova e Imperia
- Fondazione Italiana Sclerosi Multipla
- Ministero della Salute
This publication has 70 references indexed in Scilit:
- Regenerative medicine in multiple sclerosis: Identifying pharmacological targets of adult neural stem cell differentiationNeurochemistry International, 2011
- Europe rules against stem-cell patentsNature, 2011
- Impact of induced pluripotent stem cells on the study of central nervous system diseaseCurrent Opinion in Genetics & Development, 2011
- Retinoid X receptor gamma signaling accelerates CNS remyelinationNature Neuroscience, 2010
- Remyelination in the CNS: from biology to therapyNature Reviews Neuroscience, 2008
- Neuroprotective Effect of Transplanted Human Embryonic Stem Cell-Derived Neural Precursors in an Animal Model of Multiple SclerosisPLOS ONE, 2008
- Autologous haematopoietic stem-cell transplantation in multiple sclerosisThe Lancet Neurology, 2008
- Human embryonic stem cells: An experimental and therapeutic resource for neurological diseaseJournal of the Neurological Sciences, 2008
- LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitisNature Medicine, 2007
- Transplantation of Human Embryonic Stem Cell–Derived Neural Progenitors Improves Behavioral Deficit in Parkinsonian RatsThe International Journal of Cell Cloning, 2004